Saturday 12 October 2024

MCO MOVES UP IN PRESTIGIOUS CHARTIS RESEARCH RISKTECH 100 RANKINGS

NEW YORK, Oct 11 (Bernama-BUSINESS WIRE) -- Global compliance software provider MCO (MyComplianceOffice) announced that the company has once again been ranked among the world’s top risk and compliance technology solutions as part of the RiskTech100® 2025 by global research and analysis firm Chartis Research, climbing to #44 on the list.

“We’re thrilled to be acknowledged as an industry leader in the global risk and compliance technology marketplace through the rigorous Chartis benchmarking and assessment process,” noted MCO CEO Brian Fahey. “As a company we will continue to focus on innovation so we can keep delivering better compliance to our client firms, enabling them to ensure that policies and procedures are effectively implemented and monitored, and regulatory compliance is maintained across the firm.”

MCO helps firms with even the most complex regulatory obligations gain more efficient and effective compliance management while enabling cross-surveillance of the company’s employee activities, transactional conflicts of interest, and third-party relationships on a single platform with a single source of data.

In August of 2024 MCO announced the acquisition of Pythagoras Solutions, strengthening MCO’s third-party compliance capabilities and adding KYC (Know Your Customer) and AML (Anti-Money Laundering) solutions. 

Friday 11 October 2024

H2O.AI PARTNERS SINGTEL’S DIGITAL INFRACO TO DELIVER GENAI-AS-A-SERVICE



KUALA LUMPUR, Oct 11 (Bernama) -- H2O.ai, the leader in open-source generative artificial intelligence (GenAI) has announced a strategic partnership with Singtel’s Digital InfraCo to bring GenAI-as-a-Service (GenAIaaS) to organisations across Asia Pacific (APAC).

This partnership brings together H2O.ai's best-in-class GenAI and Predictive AI with Singtel AI cloud’s powerful and secure graphics processing unit (GPU) infrastructure to deliver a sovereign GenAI platform for private and public sector organisations with strict data protection needs.

“With our open source community, partnership ecosystem and unique mindset of co-creation with customers we are transforming large banks, telcos and public sector by leveraging their data, upskilling their people, and building custom GenAI and Predictive AI for solving problems and bettering life of citizens globally,” said H2O.ai Founder and Chief Executive Officer (CEO), Sri Ambati in a statement.

Meanwhile, Singtel Digital InfraCo CEO, Bill Chang said: “As organisations move toward AI-driven solutions, our partnership with H2O.ai ensures that they have access to state-of-the-art GenAI solutions developed on RE:AI’s cloud platform.

“Together, we are enabling businesses to innovate faster, enhance customer experiences, and optimise internal operations with the power of AI.”

H2O.ai GenAI software suite will be integrated with Singtel’s Paragon platform that powers Singtel AI Cloud, to enable customers to reduce time to develop and deploy AI use cases with optimal total cost of ownership (TCO).

An existing customer of H2O.ai, Singtel is expanding to offer H2O.ai full stack AI service to be integrated with Singtel Paragon platform to offer an “AI as a service” offering on Singtel GPU cloud.

The unified AI as a service solution that bundles the needed GPU infrastructure will offer customers a cost-efficient full stack AI platform for GenAI and Predictive AI to address a wide range of robust Document AI business use cases.

This collaboration between H2O.ai and Digital InfraCo marks a major step forward in bringing secure, scalable GenAIaaS to organisations across APAC while ensuring data sovereignty and compliance.

-- BERNAMA

DUCK CREEK TECHNOLOGIES ACQUIRES RISK CONTROL TECHNOLOGIES TO DELIVER COMPREHENSIVE RISK MANAGEMENT AND MITIGATION SOLUTIONS

Risk Control’s Platform Will be Fully Integrated into Duck Creek’s Comprehensive Suite of SaaS Solutions for P&C and General Insurers


BOSTON, Oct 11 (Bernama-GLOBE NEWSWIRE) -- Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) insurance, today announced it has acquired Risk Control Technologies, Inc. (“RCT”), a Toronto-based provider of risk management and loss control solutions. This strategic investment is set to transform how insurance carriers prevent loss and manage risk, enabling deployment of advanced AI and machine learning capabilities at the forefront.

“As the world faces increasing risks—whether from climate change, cyber threats, or other emerging challenges—having advanced tools to manage these exposures is crucial. Risk Control is a leader in not only identifying potential loss, but preventing it through preemptive risk mitigation,” said Mike Jackowski, Chief Executive Officer of Duck Creek Technologies. “In addition to sharing Duck Creek’s core values, Risk Control’s leadership and team members bring a wealth of insurance knowledge and experience. Together, we will help insurers work closely with their policy holders to prevent losses, improve safety and better prepare for the future.”

The RCT RiskHub platform will enhance the Duck Creek SaaS suite of insurance technology products, further increasing Duck Creek’s ability to improve underwriting accuracy, optimize claims processes, and reduce overall risk exposure. By integrating RCT’s solution into Duck Creek Technologies platform, insurance carriers will have rich predictive capabilities, enabling them to better manage underwriting risks and maximize an efficient, integrated policy and claims management experience.

“Being part of Duck Creek Technologies will strengthen our goal to help carriers optimize and increase risk-data coverage across their entire business,” said David Da Costa, Chief Executive Officer of Risk Control Technologies. “We are excited to be part of Duck Creek and to work jointly to deliver modern technology innovations that transform the insurance industry and help insurers strengthen their customer engagements and drive impactful operational efficiencies. We look forward to this new chapter and the enhanced capabilities we can now offer to the market as part of the Duck Creek family."

RCT’s industry-leading loss control and risk assessment platform will be seamlessly integrated with Duck Creek’s comprehensive suite of products to enable data-driven decisions for all stakeholders to improve proactive risk mitigation.

“I'm confident that the combined strengths of Duck Creek and Risk Control, two of our most trusted partners, will bring enhanced capabilities and innovative solutions to the market to bolster risk management and loss control,” said Murali Natarajan, Senior Vice President and Chief Information Officer of West Bend Mutual Insurance. “We look forward to the positive impact this integration will have on our underwriting process, ultimately benefiting our business and customers.”

Raymond James & Associates served as financial advisor to Risk Control Technologies on the transaction.

About Risk Control Technologies

Risk Control Technologies Inc. (RCT) is the leading provider of Risk Management and Loss Control software to the insurance industry. RCT’s RiskHub platform helps underwriting assess risk, and leverage the appropriate risk assessment tool based on the risk’s complexity. RCT helps over 150 insurance organizations improve their loss ratios, increase customer retention, implement operational efficiencies, and harness powerful data insights to enable better business decisions. RCT’s customers include a wide range of insurance organization types, operating across a broad variety of lines of business. For more information, visit www.riskcontroltech.com.

About Duck Creek Technologies

Duck Creek Technologies is the intelligent solutions provider defining the future of the property and casualty (P&C) and general insurance industry. We are the platform upon which modern insurance systems are built, enabling the industry to capitalize on the power of the cloud to run agile, intelligent, and evergreen operations. Authenticity, purpose, and transparency are core to Duck Creek, and we believe insurance should be there for individuals and businesses when, where, and how they need it most. Our market-leading solutions are available on a standalone basis or as a full suite, and all are available via Duck Creek OnDemand. Visit www.duckcreek.com to learn more. Follow Duck Creek on our social channels for the latest information – LinkedIn and X.

Media Contacts:

Marianne Dempsey/Tara Stred
duckcreek@threeringsinc.com 

SOURCE : Duck Creek Technologies

IRIUSRISK PARTNERS WITH ADAM SHOSTACK TO DELIVER THREAT MODELING COACHING SERVICES

 

  • Adam Shostack to lead the coaching with his handpicked team, which is designed to help take customer’s threat modeling skills to the next level.
  • Shostack is a leading expert on threat modeling, having produced the Microsoft SDL Threat Modeling Tool (v3) and authored Threat Modeling: Designing for Security and Threats: What Every Engineer Should Learn from Star Wars. 
ATLANTA, Oct 9 (Bernama-GLOBE NEWSWIRE) -- IriusRisk, the world’s leading Open Threat Modeling platform, has announced a partnership with Shostack + Associates to help customers build and sustain a security-first culture through effective threat modeling.

As part of the partnership, Adam Shostack, the pioneer, consultant and author on threat modeling, and his team at Shostack + Associates, will deliver coaching sessions to help users understand threat modeling to improve secure design, which will complement existing training courses on how to use IriusRisk’s automated threat modeling platform. 

The coaching will offer either 1-3 live instruction sessions over the course of a week, or self-paced, virtual sessions, focused on ensuring every member of a team has technical skills to understand and deploy threat modeling and secure by design principles. When delivered to an entire team, the coaching is designed to create a consistent baseline between those who are new to threat modeling and those who’ve learned via apprenticeship, other courses, or perhaps self-taught approaches.

The coaching will help customers overcome the stumbling blocks sometimes encountered while rolling out threat modeling, such as aligning programs with corporate goals, defining roles and responsibilities within the threat modeling programs and embedding threat modeling into existing engineering culture. 

Adam’s team will work closely with customers to determine the metrics, people, culture and processes that need to be in place to successfully integrate threat modeling into their company. By equipping leadership with the right materials, processes, and information, they can then communicate their mission back to internal stakeholders in a way that aligns with those stakeholders’ needs. 

IriusRisk empowers developers, architects, and security engineers to build secure software at every stage of the Software Development Lifecycle (SDLC). By integrating security from the initial design phase and tracking its implementation through the development toolchain, IriusRisk’s platform addresses the critical need for developers to ‘shift left’ on security, minimizing design flaws and cutting associated costs.

“We’re excited to partner with Adam to deliver this new coaching program,” said Stephen de Vries, Co-Founder and CEO of IriusRisk. “As threat modeling rapidly becomes a must-have strategy for security and development teams, this coaching equips our customers with the essential skills to implement successful threat modeling programs and effectively champion its value across their organization.” 

“Threat modeling, in a lot of ways, isn’t just technical steps for security and developer teams - it’s a cultural shift in how they operate. To master it, you need to have the right information and tools.” added Adam Shostack. “That’s why we’re proud to partner with IriusRisk to help its customers tackle teething issues around implementing threat modeling and deliver a successful program that can scale.” 

The coaching is aimed specifically at the leadership owning a threat modeling program in both the North American and international markets. 

For more information please visit https://www.iriusrisk.com/shostack-associates-coaching 

Wednesday 9 October 2024

CURIA UNVEILS BRAND REFRESH AT CPHI WW IN MILAN

The refined brand highlights Curia’s key capabilities and personalized approach across small molecules, generic APIs and biologics

ALBANY, N.Y., Oct 8 (Bernama-GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today unveiled its refreshed brand. The update introduces refined corporate messaging and a new brand hierarchy, highlighting the breadth of Curia’s CDMO capabilities across small molecules, generic APIs and biologics. This brand update underscores Curia’s role as a dedicated ally to its clients, leveraging 30+ years of industry experience and a robust global presence to accelerate product timelines by addressing both simple and complex challenges across drug discovery, development and manufacturing.

The brand refresh includes:
 
• Three distinct commercial service logos – Curia has established brand logos for each of its three key service offerings across small molecules, generic APIs and biologics. This new hierarchy of service logos clearly communicates Curia’s robust portfolio of services and solutions.
• Revamped website – Curia is pleased to simultaneously launch its updated website. The evolved design improves the user experience for clients and prospects seeking best-in-class contract development and manufacturing services in small molecules, generic APIs, biologics, analytical services and sterile fill-finish. 

Tuesday 8 October 2024

PHILIPS, SILOAM HOSPITALS GROUP TO BACK INDONESIA’S HEALTHCARE TRANSFORMATION STRATEGY

KUALA LUMPUR, Oct 7 (Bernama) -- Royal Philips, a global leader in health technology, and Siloam Hospitals Group, Indonesia’s private healthcare provider, have signed a memorandum of understanding (MoU) to advance artificial intelligence (AI) capabilities and development in the healthcare sector in Indonesia.

The strategic collaboration, in partnership with the Universitas Pelita Harapan (UPH) Medical Sciences Group, will focus on capacity building, knowledge sharing, and implementing advanced AI solutions.

“At Philips, we believe that informatics and AI will help transform healthcare by optimising workflows, improving efficiency and increasing capacity, making healthcare more accessible and delivering better care for more people.

“We are excited to collaborate with Siloam Hospitals and Universitas Pelita Harapan to drive this transformation and fully support the Indonesian government’s vision of improving healthcare through digital innovation,” said Royal Philips Chief Executive Officer, Roy Jakobs in a statement.

Meanwhile, Siloam Hospitals Group Deputy President Director, Caroline Riady said: “This partnership with Philips, Siloam Hospitals and Universitas Pelita Harapan is a significant milestone in our journey to bring advanced healthcare technologies to Indonesia.

“By investing in AI capability and sharing global expertise, we are helping to build a smarter, more efficient healthcare system that will benefit millions of Indonesians and support the national healthcare agenda.”

Key areas of focus in the partnership include AI-driven clinical care; global knowledge sharing with Philips; digital health transformation; supporting the Indonesian government’s healthcare goals; and expertise sharing for driving environmental, social and governance (ESG) in healthcare.

Leveraging Philips’ AI innovations, the collaboration will help transform clinical care and digital health, enhance healthcare delivery and make the healthcare infrastructure more sustainable, with the goal of delivering better care for more people in Indonesia.

In addition, this partnership aligns with the Indonesian government’s healthcare strategy to improve healthcare accessibility, enhance clinical outcomes, and embrace digital transformation.

-- BERNAMA

Monday 7 October 2024

MYT NETHERLANDS PARENT B.V. ("MYTHERESA") AND RICHEMONT SIGN AGREEMENT FOR MYTHERESA TO ACQUIRE YOOX NET-A-PORTER ("YNAP") TO CREATE LEADING, GLOBAL, MULTI-BRAND DIGITAL LUXURY GROUP IN EXCHANGE FOR A 33% EQUITY STAKE IN MYTHERESA



AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
7 OCTOBER 2024
 
  • Richemont will sell YNAP to Mytheresa with a cash position of €555m and no financial debt, subject to customary closing adjustments
  • Mytheresa to issue shares to Richemont representing 33% of Mytheresa’s fully diluted share capital
  • Richemont to provide a €100m revolving credit facility to YNAP
  • Closing of transaction expected in H1 2025, subject to customary conditions, including regulatory approvals
  • Transaction creates multi-brand digital group of significant scale, global reach as well as exceptional customer centricity


MUNICH & GENEVA, Switzerland, Oct 7 (Bernama-BUSINESS WIRE) -- Today, Mytheresa (NYSE:MYTE) and Richemont (SWX:CFR) announce that they have entered into binding agreements for the acquisition of 100% of the share capital of YNAP by Mytheresa. The transaction aims to create a leading, global, multi-brand digital luxury group offering a highly curated and strongly differentiated edit of the most prestigious luxury brands and products to luxury enthusiasts worldwide.

Transaction Rationale

Mytheresa and YNAP have each earned a strong reputation in the luxury industry for their pioneering roles in innovation, authoritative editorial voice and curation, as well as high-quality customer service. Together, the different storefronts cover a broad spectrum of the luxury market with distinct propositions in terms of brand portfolio, customer and geographical focus while sharing the strategic positioning towards high end customers.

In the medium term, Mytheresa’s vision for the combined group entails:
  • The integration of YNAP’s Luxury division into Mytheresa, to form one group with three distinct storefronts: MYTHERESA, NET-A-PORTER and MR PORTER, which is expected to:
    • Provide a broader and further differentiated luxury offering towards customers based on distinctive assortments, marketing and customer touchpoints;
    • Offer luxury brand partners an even broader and specific reach of luxury consumers worldwide as a result of distinctive curation and inspiration; and
    • Share infrastructure including Mytheresa`s technology platform and operational best practices to facilitate greater efficiencies while maintaining their distinct brand identities.
  • The separation of the off-price division - comprising YOOX and THE OUTNET, leading destinations for online off-price luxury shopping - from the Luxury division to allow for a simpler and more efficient operating model driving higher growth and profitability.
  • The discontinuation of YNAP’s white label division, once the Richemont Maisons’ online stores powered by YNAP migrate to their own chosen platforms.
Michael Kliger, CEO of Mytheresa, said: “I am truly excited by today’s announcement. With this transaction, Mytheresa aims to create a pre-eminent, multi-brand, digital, luxury group worldwide. MYTHERESA, NET-A-PORTER and MR PORTER will offer differentiated but complementary multi-brand luxury edits based on curation, inspiration and outmost customer service. The three brands will share a large part of their infrastructure creating synergies and efficiencies while maintaining their different brand identities. The off-price business will benefit from the separation from luxury and a much simpler operating model driving growth and profitability. We believe that this transaction will create significant value for our shareholders, brand partners and most importantly for our high-end customers.”

Johann Rupert, Chairman of Richemont, said: “We are pleased to have found such a good home for YNAP. As a trusted partner to many of the world’s leading global luxury brands, YNAP is renowned for its pioneering high-end customer services complemented by its distinctive and inspirational editorial voice. Mytheresa is ideally placed to build on YNAP’s assets to further delight customers and brand partners alike across the world by harnessing both companies’ respective strengths.”

Financial consideration

At transaction closing, Richemont will sell YNAP to Mytheresa with a cash position of €555m and no financial debt, subject to customary closing adjustments, in exchange for shares to be issued by Mytheresa representing 33% of Mytheresa’s fully dilutedshare capital at closing following issuance of the consideration shares. Richemont will make available a 6-year revolving credit facility of €100m to finance YNAP’s general corporate needs, including working capital.

Richemont will have the right to nominate a member and an observer to the Supervisory Board of Mytheresa following closing.

Closing of the transaction, which is expected to occur in the first half of calendar year 2025, is subject to customary conditions, including the receipt of antitrust approvals.

The transaction is not subject to or conditional on approval by either Richemont or Mytheresa shareholders.

Richemont’s shareholding in Mytheresa will be subject to a one-year lock-up period following transaction closing, followed by a further one-year period in which only certain limited sale transactions may take place.

As a result of this transaction, Richemont currently expects the write-down of YNAP net assets to amount to approximately €1.3 billion, which also accounts for the cash to be left in YNAP upon completion. This value is subject to change until completion date as it depends on several variables, namely Mytheresa’s share price, the USD/EUR foreign exchange rate, the value of net assets and debt-like items of YNAP at completion date.

Conference Call Information

Mytheresa will host a conference call to discuss the transaction at 8am Eastern Time. Those wishing to participate via webcast should access the call through Mytheresa’s Investor Relations website at https://investors.mytheresa.com. Those wishing to participate via the telephone may dial in at +1 800 715 9871 (USA). The participant access code will be 3814635. The conference call replay will be available via webcast through Mytheresa’s Investor Relations website. The telephone replay will be available from 10am Eastern Time on October 7, 2024, through October 14, 2024, by dialing +1 800 770 2030 (USA). The replay passcode will be 3814635.

Forward Looking Statements

This release contains forward-looking statements as that term is defined in the United States Private Securities Litigation Reform Act of 1995. All statements contained in this release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the timing and completion of and expected benefits from the transactions involving Richemont Maisons, NET-A-PORTER and YNAP, expectations regarding future opportunities and our market position, our business plans and strategy, future financial or operating performance, as well as statements that include the words “expect,” “plan,” “believe,” “estimate,” “may,” “should,” “anticipate,” “will,” “could,” “aim,” “continue” and similar statements of a future or forward-looking nature. Such forward-looking statements are not guarantees of future performance. Richemont’s forward-looking statements are based on management’s current expectations and assumptions regarding YNAP’s business and performance, the economy and other future conditions and forecasts of future events, circumstances and results. Our retail stores are heavily dependent on the ability and desire of consumers to travel and shop and a decline in consumer traffic could have a negative effect on our comparable store sales and/or average sales per square foot and store profitability resulting in impairment charges, which could have a material adverse effect on our business, results of operations and financial condition. Reduced travel resulting from economic conditions, retail store closure orders of civil authorities, travel restrictions, travel concerns and other circumstances, including disease epidemics and other health-related concerns, could have a material adverse effect on us, particularly if such events impact our customers’ desire to travel to our retail stores. International conflicts or wars, including resulting sanctions and restrictions on importation and exportation of finished products and/or raw materials, whether self-imposed or imposed by international countries, non-state entities or others, may also impact these forward-looking statements. As with any projection or forecast, forward-looking statements are inherently susceptible to uncertainty and changes in circumstances. Actual results may differ materially from the forward-looking statements as a result of a number of risks and uncertainties, many of which are outside Richemont’s control. Accordingly, you should not rely upon forward-looking statements as predictions of future events. In addition, the forward-looking statements made in this release relate only to events or information as of the date on which the statements are made in this release. Richemont does not undertake to update, nor does it have any obligation to provide updates of, or to revise, any forward-looking statements.

This press release contains “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact or relating to present facts or current conditions included in this press release are forward- looking statements. Forward-looking statements give Mytheresa’s current expectations and projections relating to the proposed transaction and the operation of the combined companies; its financial condition, results of operations, plans, objectives, future performance and business, including statements relating to financing activities, future sales, expenses, and profitability; future development and expected growth of our business and industry; our ability to execute our business model and our business strategy; having available sufficient cash and borrowing capacity to meet working capital, debt service and capital expenditure requirements for the next twelve months; and projected capital spending. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements contained in this press release are based on assumptions that Mytheresa has made in light of its industry experience and perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. As you read and consider this press release, you should understand that these statements are not guarantees of performance or results. They involve risks, uncertainties (many of which are beyond Mytheresa’s control) and assumptions. Although Mytheresa believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect its actual operating and financial performance and cause its performance to differ materially from the performance anticipated in the forward-looking statements. Mytheresa believes these factors include, but are not limited to: the occurrence of any event, change or other circumstances that could give rise to the termination or abandonment of the proposed transaction; the expected timing and likelihood of completion of the proposed transaction with Richemont, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed transaction that could reduce anticipated benefits or cause the parties to abandon the transaction; the risk that the conditions to closing the proposed transaction may not be satisfied in a timely manner or at all; the risk that the proposed transaction and its announcement could have an adverse effect on the ability of YNAP to retain customers and retain and hire key personnel and maintain relationships with their brand partners and customers and on their operating results and businesses generally; the risk that problems may arise in successfully integrating the businesses of YNAP and Mytheresa, which may result in the combined company not operating as effectively and efficiently as expected; the risk that the combined company may be unable to achieve cost-cutting synergies or that it may take longer than expected to achieve those synergies; Mytheresa’s ability to effectively compete in a highly competitive industry; Mytheresa’s ability to respond to consumer demands, spending and tastes; Mytheresa’s ability to respond to any current or future health epidemic or other adverse public health development; Mytheresa’s ability to acquire new customers and retain existing customers; consumers of luxury products may not choose to shop online in sufficient numbers; the volatility and difficulty in predicting the luxury fashion industry; Mytheresa’s reliance on consumer discretionary spending; and Mytheresa’s ability to maintain average order levels and other factors. Should one or more of these risks or uncertainties materialize, or should any of these assumptions prove incorrect, Mytheresa’s actual operating and financial performance may vary in material respects from the performance projected in these forward-looking statements.

Mytheresa undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.

The achievement or success of the matters covered by such forward-looking statements involves known and unknown risks, uncertainties and assumptions. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, Mytheresa’s results could differ materially from the results expressed or implied by the forward-looking statements it makes.

You should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent Mytheresa’s management’s beliefs and assumptions only as of the date such statements are made.

Further information on these and other factors that could affect Mytheresa’s financial results is included in filings it makes with the U.S. Securities and Exchange Commission (“SEC”) from time to time, including the section titled “Risk Factors” in its annual report on Form 20-F and on Form 6-K (reporting its quarterly results). These documents are available on the SEC’s website at www.sec.gov and on the SEC Filings section of the Investor Relations section of our website at: https://investors.mytheresa.com.

About Mytheresa

Mytheresa is one of the leading luxury multi-brand digital platforms shipping to over 130 countries. Founded as a boutique in 1987, Mytheresa launched online in 2006 and offers ready-to-wear, shoes, bags and accessories for womenswear, menswear, kidswear as well as lifestyle products and fine jewelry. The highly curated edit of up to 250 brands focuses on true luxury brands such as Bottega Veneta, Brunello Cucinelli, Dolce&Gabbana, Gucci, Loewe, Loro Piana, Moncler, Prada, Saint Laurent, The Row, Valentino, and many more. Mytheresa’s unique digital experience is based on a sharp focus on high-end luxury shoppers, exclusive product and content offerings, leading technology and analytical platforms as well as high quality service operations. The NYSE listed company reported € 913.6 million GMV in fiscal year 2024 (+7% vs. FY23). For more information, please visit https://investors.mytheresa.com/.

About Richemont

At Richemont, we craft the future. Our unique portfolio includes prestigious Maisons distinguished by their craftsmanship and creativity. Richemont’s ambition is to nurture its Maisons and businesses and enable them to grow and prosper in a responsible, sustainable manner over the long term.

Richemont operates in three business areas: Jewellery Maisons with Buccellati, Cartier, Van Cleef & Arpels and Vhernier; Specialist Watchmakers with A. Lange & Söhne, Baume & Mercier, IWC Schaffhausen, Jaeger-LeCoultre, Panerai, Piaget, Roger Dubuis and Vacheron Constantin; and Other, primarily Fashion & Accessories Maisons with Alaïa, Chloé, Delvaux, dunhill, Gianvito Rossi, Montblanc, Peter Millar including G/FORE, Purdey, Serapian as well as Watchfinder & Co. In addition, Richemont operates NET-A-PORTER, MR PORTER, THE OUTNET, YOOX and the OFS division.

Richemont ‘A’ shares are listed and traded on the SIX Swiss Exchange, Richemont’s primary listing, and are included in the Swiss Market Index ('SMI') of leading stocks. The ‘A’ shares are also traded on the JSE Johannesburg Stock Exchange, Richemont’s secondary listing.

About YOOX NET-A-PORTER (YNAP)

YNAP is a world leading online luxury and fashion retailer, with a distinctive offering including multi-brand in-season online stores NET-A-PORTER and MR PORTER, and multi-brand off-season online stores YOOX and THE OUTNET.

Uniquely positioned in the high growth online luxury sector, YNAP has a client base of c.4 million high-spending customers and over 900 million visitors worldwide. The Group has offices and operations in the United States, Europe, Middle East, Japan, mainland China and Hong Kong SAR, China. It delivers to over 170 countries around the world.

Mytheresa’s fully diluted share capital includes outstanding issued shares, plus probability-adjusted vested and unvested RSU / PSU and stock options plans.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241006718886/en/

Contact

Mytheresa Contacts
Media Contacts for public relations
Mytheresa.com GmbH
Sandra Romano
mobile: +49 152 54725178
email: sandra.romano@mytheresa.com

Media Contacts for business press
Mytheresa.com GmbH
Lisa Schulz
mobile: +49 151 11216490
email: lisa.schulz@mytheresa.com

Investor Relations Contacts
Mytheresa.com GmbH
Stefanie Muenz
mobile: +49 89 127695-1919
email: investors@mytheresa.com

Richemont Contacts
Investor / analyst enquiries: +41 22 721 30 03; investor.relations@cfrinfo.net
Media enquiries: +41 22 721 35 07; pressoffice@cfrinfo.netrichemont@teneo.com

Media Contacts for business press
BOC Consult GmbH
Ruediger Assion
mobile: +49 176 2424 7691
email: ruediger.assion@boc-consult.com

Source : MYT Netherlands Parent B.V.

Friday 4 October 2024

DUCK CREEK PAYMENTS FACILITATOR PROVIDES SEAMLESS END-TO-END INSURANCE PAYMENT SOLUTION

KUALA LUMPUR, Oct 3 (Bernama) -- Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, introduced its latest insurance-focused payments solution, the Duck Creek Payments Facilitator.

According to Duck Creek Technologies in a statement, this modern, end-to-end payment solution caters to the nuances of payments within insurance by providing carriers with access to digital payment methods for both collecting and disbursing funds.

Its Chief Executive Officer, Michael Jackowski said the Duck Creek Payments Facilitator is designed specifically to address the unique operational demands of insurance carriers.

“By embedding this capability into our broader platform, we are offering carriers a holistic approach that supports flexibility, boosts efficiency, and helps our clients deliver a frictionless experience for policyholders, agents, and vendors,” he said.

Meanwhile, its Chief Product and Technology Officer, Jess Keeney said: “In today’s fast-evolving insurance landscape, carriers require more than just transactional solutions. They need a secure, agile, and future-proof approach to global payment processing.

“The Duck Creek Payments Facilitator delivers exactly that, enabling insurers to effortlessly manage instant claims payouts to real-time premium payments, all from a single, proven solution.”

Duck Creek Payments Facilitator delivers a global solution, combining real-time capabilities, like FedNow, with traditional payments services and Banking as a Service (BaaS) functionalities, such as transactions via push-to-card or digital wallets.

Now insurers can collect or pay out to policyholders using any payment technologies in their market of choice.

Duck Creek Payments includes Duck Creek Payments Facilitator and Duck Creek Payments Orchestrator, introduced earlier this year.

-- BERNAMA

BUSINESSNEXT-MongoDB Collaboration Powering Autonomous Operations In Financial Services

KUALA LUMPUR, Sept 30 (Bernama) -- BUSINESSNEXT, a global leader in composable enterprise solutions for financial services, has partnered with New York-based MongoDB to accelerate autonomous operations powered with specialised predictive and generative artificial intelligence (Gen AI) for banking and insurance.

According to a statement, the collaboration between BUSINESSNEXT and MongoDB will empower banking and financial services with the technology needed to deliver exceptional customer experiences and drive autonomous operations.

BUSINESSNEXT Executive Director, Sushil Tyagi said the company is excited to partner with MongoDB to deliver cutting-edge solutions to its financial services clients.

“MongoDB’s industry-leading data protection protocols and our ability to handle complex data structures and scale effortlessly aligns with our vision of providing a modern, agile platform for banks,” he said.

Meanwhile, MongoDB Vice President, India and South Asia, Sachin Chawla said: “This partnership will help a large number of financial services organisations to accelerate their modernisation initiatives and use AI to drive differentiation.”

By combining BUSINESSNEXT’s deep expertise in financial services with MongoDB’s flexible, scalable database platform that has industry-leading encryption, access controls, and data protection protocols, the partnership will deliver innovative solutions that address the evolving needs of the industry.

BUSINESSNEXT’s suite of solutions to drive autonomous banking includes real-time AI at the core powering modern customer relationship management (CRM), digital journeys, lending platforms, risk-rating platforms, workforce assistants, and customer chatbots.

MongoDB’s document-oriented data model, with its flexible schema, nicely complements BUSINESSNEXT’s AI-driven capabilities. The partnership will enable banks to harness the power of their data to create personalised customer journeys, optimise lending processes, and make data-driven decisions.

Key benefits of the partnership include autonomous banking operations; enhanced customer experiences; accelerated lending processes; improved operational efficiency; and strengthened risk management.

This partnership also marks a significant milestone for both companies, and it is expected to drive significant value for financial institutions worldwide.

-- BERNAMA


Thursday 3 October 2024

CURIUM ANNOUNCES STRATEGIC PARTNERSHIP WITH PEPTIDREAM FOR PROSTATE CANCER THERANOSTICS IN JAPAN

  • Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T
  • Builds on long-standing relationship between the two companies
  • In Japan around 90,000 new cases of prostate cancer are diagnosed each year
PARIS, Oct 2 (Bernama-GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has entered into a strategic partnership with PDRadiopharma Inc, a wholly-owned subsidiary of PeptiDream, for the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T. The two agents 177Lu-PSMA-I&T and 64Cu-PSMA-I&T target prostate specific membrane antigen (PSMA) expressed on prostate cancer cells and are being investigated for prostate cancer treatment and diagnostics. Both target tumors with high levels of PSMA expression and thus potentially forming a theranostic (therapeutic & diagnostic) pair.

Under the terms of the partnership, Curium and PDRadiopharma will jointly collaborate on clinical development activities of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T in Japan, with PDRadiopharma leading regulatory filing, manufacturing, commercialization, and distribution activities in Japan. Curium will continue to lead global development of the two agents and support PDRadiopharma through technology transfer to support the set-up of manufacturing lines in Japan – including a high throughput Copper 64 manufacturing line based on Curium’s proprietary technology.

Patrick C. Reid, President & CEO of PeptiDream commented: “Targeted radiopharmaceuticals are rapidly revolutionizing how we both diagnose and treat cancer. At PeptiDream and PDRadiopharma we are focused on expanding our pipeline of these powerful targeted therapies, and we are thrilled to be able to accelerate those efforts by partnering with Curium to bring their highly promising prostate cancer targeting radiopharmaceuticals to patients in Japan.”

Masato Murakami, President of PDRadiopharma & CMO of PeptiDream commented: “We are excited to partner with Curium in the development of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T, highly promising products for both the diagnosis and treatment of PSMA-expressing prostate cancer. We look forward to working with Curium to deliver these much-needed agents to prostate cancer patients in Japan as quickly as possible.”

Chaitanya Tatineni, Curium’s CEO International Markets commented: “As a global innovator in the field of radiopharmaceuticals with a promising late-stage oncology pipeline, Curium is delighted to partner with PDRadiopharma which has more than four decades of experience in Japan. Curium and PDRadiopharma plan to leverage their complementary strengths to accelerate the development of innovative products for the benefit of prostate cancer patients in Japan.”

Prostate cancer continues to be widely prevalent in Japan. Annually, there are approximately 90,000 – 100,000 new cases, with patients with metastatic castration-resistant prostate cancer having an overall survival rate of approximately three years in clinical trial settings, and even shorter in the real-world, and there remains a significant unmet medical need for therapies.

177Lu-PSMA-I&T, a PSMA inhibitor conjugated with the radioisotope Lutetium 177, is currently being tested by Curium in a global pivotal Phase 3 ECLIPSE trial (ClinicalTrials.gov identifier; NCT05204927). ECLIPSE is a multi-center, open-label, randomized clinical trial comparing the safety and efficacy of 177Lu-PSMA-I&T versus hormone therapy in patients with metastatic castration-resistant prostate cancer. The ECLIPSE trial enrolled over 400 patients, across 51 trial sites in the United States and Europe.

64Cu-PSMA-I&T PET is currently being investigated in 2 multicenter Phase 3 trials; SOLAR RECUR testing the diagnostic performance in men with biochemical recurrence of prostate cancer (ClinicalTrials.gov identifier NCT06235099) and SOLAR STAGE testing the diagnostic performance in men with newly diagnosed unfavorable intermediate- to high-risk prostate cancer (ClinicalTrials.gov identifier; NCT06235151). The first in human Phase 1/2 SOLAR trial met the co-primary endpoints of region-level correct localization rate and patient-level correct detection rate in patients with histologically-proven metastatic prostate cancer. PSMA-targeted PET/CT imaging is increasingly emerging as a highly sensitive method for detection of locally recurrent or metastatic lesions in the context of biochemical recurrence and for localization of primary prostate cancer.

Curium and PDRadiopharma have a long-standing relationship in the radiopharmaceutical field.

For more information:

PeptiDream Inc.
Yuko Okimoto, IR & Public Affairs
info@peptidream.com

PDRadiopharma Inc.
Noriko Tanaka, General Affairs
s-info-hq@pdradiopharma.com

Curium
Ross Bethell
VP, Head of Global Communications
communications@curiumpharma.com

About PeptiDream Inc.
PeptiDream Inc. (Tokyo Stock Exchange Prime Market 4587) is leading the translation of macrocyclic peptides into a whole new class of innovative medicines to address unmet medical needs and improve the quality of life of patients worldwide. In its radiopharmaceutical business, through its wholly-owned subsidiary PDRadiopharma, PeptiDream markets and sells a number of approved radiopharmaceuticals and radiodiagnostics in Japan, as well as leveraging its proprietary Peptide Discovery Platform System (PDPS) technology to discover and develop a deep pipeline of innovative targeted radiotherapeutics and radiodiagnostics, spanning both wholly-owned internal programs and globally partnered programs. In its non-radiopharmaceutical business, PeptiDream is similarly leveraging PDPS to discover and develop a broad and diverse pipeline of investigational peptide therapeutics, peptide drug conjugates (PDC) and multi-functional peptide conjugates (MPC) across an extensive global network of discovery and development partners.   PeptiDream is headquartered in Kawasaki, Japan. For more information about our company, science and pipeline, please visit www.peptidream.com/en

About PDRadiopharma
PDRadiopharma, a wholly-owned subsidiary of PeptiDream since 2022, has been providing high-quality radiopharmaceuticals through the research and development, manufacturing, regulatory and sales as a forerunner in the field in radiopharmaceuticals, since it started its business in 1968. PDRadiopharma currently markets 21 radiodiagnostic products (spanning both SPECT and PET products) and 8 radiotherapeutic products (3 product categories) in Japan. Additionally, PDRadiopharma and PeptiDream are developing a broad pipeline of radiotherapeutics and radiodiagnostics for both the Japan and global markets. For more information about PDRadiopharma, please visit www.pdradiopharma.com/en

About Curium
Curium is a world leader in nuclear medicine. We develop, manufacture, and distribute world-class radiopharmaceutical products to help patients around the globe. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service. With manufacturing facilities across Europe and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for life-threatening diseases to over 14 million patients annually. The name ‘Curium’ honors the legacy of pioneering radioactive materials researchers Marie and Pierre Curie, after whom the radioactive element curium was named and emphasizes our focus on nuclear medicine. To learn more, visit www.curiumpharma.com     

Source: Curium US LLC 

http://mrem.bernama.com/viewsm.php?idm=49438

Tuesday 1 October 2024

UBIQUBE STRENGTHENS BOARD WITH CLOUD AND SECURITY VETERANS TO DRIVE AGILEOPS VISION AND GLOBAL EXPANSION


DUBLIN, Oct 1 (Bernama-GLOBE NEWSWIRE) -- UBiqube, a leader in hybrid cloud and security infrastructure automation, today announced the appointment of two seasoned executives, Jean-David Lehmann-Charley and Ahmed Guetari, to its Board of Directors. Both leaders bring extensive expertise in network, security, and cloud technologies, with proven track records in driving innovation and growth in the service provider industry.

Their addition comes at a pivotal time for UBiqube as it embarks on its Agile Ops journey, implementing scalable, automated solutions for CloudOps, NetOps, and SecOps practices. They will join our distinguished directors from NTT and Fujitsu and complete the board with relevant skills to drive the adoption of UBiqube’s innovation.

Jean-David Lehmann-Charley is Regional Sales VP, Cortex ecosystem EMEA and Latam for Palo Alto Networks. He brings over 20 years of experience in complex sales, direct and indirect, in the network & security market across EMEA and Latam at Palo Alto and before that at Juniper. Jean-David is an entrepreneurial sales leader; his field expertise and acumen will be essential to UBiqube's governance. “I welcome the opportunity to contribute to UBiqube's growth and reputation as a Hybrid cloud automation solution provider,” said Jean-David. “In an industry notoriously plagued with complexity and tools inflation, it is encouraging to see UBiqube’s focus on solutions simplifying Cloud and Security operations through automation. It is an essential endeavor to ensure the IT infrastructure is ready to weather the upcoming ‘AI Tsunami.'

Ahmed Guetari is GM and VP of products for Service Providers at F5. He brings over 20 years of industry experience with Juniper and now F5. Ahmed is an industry-wide recognized strategic thinker with a passion for delivering technology with purpose. He is a hands-on product head, and his leadership is deeply rooted in his understanding of the operational reality of his customers. He is the field technologist the UBiqube board needs. “The convergence of Cloud and network paradigms, the emergence of the edge as a cloud proxy and the exponential growth in datacenters all aimed at addressing the monumental AI processing needs. These transformational trends call for solutions focused on scaling operations through simplification and process automation. UBiqube is at the forefront of this innovation field and has demonstrated this to various customers and use cases,' said Ahmed. “I am enthusiastic about joining UBiqube's board and helping the team open the next chapter of their growth.”

Nabil Souli, CEO of UBiqube, welcomed the new board members: “I am humbled and proud of the endorsement of the addition of Jean-David and Ahmed to our board represents. Their experience and industry knowledge will be invaluable as we scale our operations and continue to expand into global markets. Their guidance will strengthen our partnerships with system integrators and enable us to drive operational agility adoption for an IT infrastructure rising to the AI challenge.”

About UBiqube:

Based in Dublin, Ireland, UBiqube is a leading provider of infrastructure automation aimed at dramatically simplifying Cloud ops, Netops and Secops. We partner with leading system integrators worldwide to design and deliver tailored solutions that address the complexity of an ever-changing IT infrastructure landscape. Learn more at www.ubiqube.com.

Media Contacts:
Colin Fernandes, Head of Marketing
Email: cfe@ubiqube.com

SOURCE : UBiqube (Ireland) Limited